Eli Lilly

Senate Hearing Exposes PBM Insulin Profiteering: 75% of Sales Go to Rebates and Fees

| Importance: 9/10

The Senate Health, Education, Labor, and Pensions (HELP) Committee held a historic hearing bringing together CEOs of major insulin manufacturers (Eli Lilly, Novo Nordisk, Sanofi) and executives from the three largest PBMs (CVS Caremark, Express Scripts, OptumRx) to examine soaring insulin prices. …

Bernie Sanders Senate HELP Committee Lars Fruergaard Jorgensen Paul Hudson Heather Cianfrocco +6 more healthcare pbm pharmacy insulin drug-pricing +2 more
Read more →

Alex Azar Confirmed as HHS Secretary After Doubling Insulin Prices at Eli Lilly

| Importance: 9/10

On January 24, 2018, the Senate confirmed Alex Azar as Secretary of Health and Human Services by a vote of 55-43, installing as the nation’s top healthcare regulator a pharmaceutical executive who had overseen dramatic insulin price increases during his decade at Eli Lilly. As President of …

Alex Azar Eli Lilly Department of Health and Human Services Ron Wyden Donald Trump revolving-door regulatory-capture healthcare pharmaceutical-industry insulin-pricing +3 more
Read more →

Eli Lilly, Novo Nordisk, and Sanofi Sued for Insulin Price-Fixing Conspiracy as Prices Rise 300%+

| Importance: 9/10

In January 2017, diabetes patients filed a federal antitrust class action lawsuit alleging that the three pharmaceutical manufacturers controlling 99% of the U.S. insulin market—Eli Lilly, Novo Nordisk, and Sanofi—conspired to raise insulin prices in near-lockstep coordination, increasing prices by …

Eli Lilly Novo Nordisk Sanofi CVS Caremark Express Scripts +1 more healthcare pharmaceutical-price-gouging antitrust corporate-crime regulatory-capture
Read more →

Insulin Prices Begin Tripling 2002-2013 as Three Manufacturers Control 99% of Market - From $231 to $762 Annually

| Importance: 9/10

The average price of insulin in the United States began a decade-long tripling from $231 per patient annually in 2002 to $762 in 2013, according to congressional hearing data—with some patients paying up to $900 per month for insulin products that cost $4.34 per milliliter in 2002 but reached $12.92 …

Eli Lilly Novo Nordisk Sanofi Congressional Diabetes Caucus Big Pharma pharmaceutical-industry drug-pricing healthcare monopoly insulin-crisis +1 more
Read more →

ALEC Corporate Membership Explodes as Major Corporations Overwhelm Organization with Requests for Legislative Access

| Importance: 8/10

By 1984, ALEC’s corporate membership had grown so rapidly that Executive Director Kathleen Teague reported corporations were overwhelming the organization’s capacity. Major corporations supporting ALEC that year included Edison Electric Institute, Procter & Gamble Co., Mary Kay …

American Legislative Exchange Council (ALEC) Kathleen Teague Edison Electric Institute Procter & Gamble Eli Lilly +5 more corporate-capture legislative-capture alec corporate-membership lobbying +1 more
Read more →

American Enterprise Association Moves to Washington to Oppose New Deal, Precursor to AEI Think Tank

| Importance: 7/10

The American Enterprise Association (AEA) moves its main offices from New York City to Washington, D.C. in 1943 to more effectively oppose the New Deal and capitalize on Congress’s need for help making sense of its vastly increased wartime portfolio. AEA was founded in 1938 by a group of New …

American Enterprise Association Lewis H. Brown Johns-Manville Corporation Henry Hazlitt Bristol-Myers +5 more american-enterprise-institute aei think-tanks new-deal-opposition corporate-funding +1 more
Read more →